Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy

by Schrappe Martin, Handgretinger Rupert, Faldum Andreas, Hero Barbara, Simon Thorsten, Klingebiel Thomas, Berthold Frank
Published 2011-01-01